5.45 USD
↘ 0.37 (6.36%)AT CLOSE (11:59 AM EDT)
Clene Inc. Common Stock
CLNNNASDAQ • USD
5.47
↗ 0.01 (0.28%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
5.47
↗ 0.01 (0.28%)
Market: OPEN
Open?$5.77
High?$5.77
Low?$5.38
Prev. Close?$5.82
Volume?114.7K
Avg. Volume?937.6K
VWAP?$5.56
Rel. Volume?0.12x
Bid / Ask
Bid?$4.55 × 100
Ask?$6.50 × 100
Spread?$1.95
Midpoint?$5.53
Valuation & Ratios
Market Cap?74.4M
Shares Out?12.8M
Float?8.3M
Float %?70.3%
P/E Ratio?N/A
P/B Ratio?-3.95
EPS?-$2.62
Dividend?0.00%
Ex-Dividend?N/A
Shares of Clene Inc. Common Stock (CLNN) are trading at $5.47. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Strong Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, exceptional Return on Equity (177.9%) and a bearish Death Cross on the long-term moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
Themes
Address
6550 SOUTH MILLROCK DRIVE, SUITE G50
SALT LAKE CITY, UT 84121
Phone: 801-676-9695
SALT LAKE CITY, UT 84121
Phone: 801-676-9695
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookStrong Sell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?0
Momentum?3
Short Sent.?34
Piotroski F-Score?2/9Weak
Altman Z-Score?-22.20Distress
Confidence?64%Moderate
Short InterestHigh
Short % of Float?15.98%High
Short Interest?1.3M
Days to Cover?1.0
Free Float8.3M
Avg Daily Volume2.3M
Settlement Date2026-05-15
Financial Health
Current Ratio?1.94Adequate
Quick Ratio?1.93Adequate
Cash Ratio?0.88Adequate
Debt/Equity?-0.97Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-3.95CHEAP▾
S&P97
P/S?555.00HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-4.4CHEAP▾
S&P97
EV/Sales?646.54HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?177.9%STRONG▾
Peers50
S&P97
ROA?-154.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-18102000
Enterprise Value?$86.6M
Fundamentals ratios updated end of day